These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


84 related items for PubMed ID: 3758467

  • 1. Carteolol treatment of essential hypertension: a long-term study of safety and efficacy.
    Luther RR, Maurath CJ, Klepper MJ, Peckinpaugh RO, Ringham GL.
    J Int Med Res; 1986; 14(4):175-84. PubMed ID: 3758467
    [Abstract] [Full Text] [Related]

  • 2. Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity.
    Giles TD, Sander GE, Roffidal L, Thomas MG, Mersch DP, Moyer RR, Burris JF, Mroczek WJ, Brachfeld J.
    Arch Intern Med; 1988 Aug; 148(8):1725-8. PubMed ID: 3041936
    [Abstract] [Full Text] [Related]

  • 3. Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent.
    Luther RR, Glassman HN, Jordan DC, Klepper MJ.
    J Int Med Res; 1986 Aug; 14(4):167-74. PubMed ID: 3093295
    [Abstract] [Full Text] [Related]

  • 4. [Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol].
    Werning C.
    Arzneimittelforschung; 1983 Aug; 33(2a):325-30. PubMed ID: 6682324
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of essential hypertension with the beta-receptor antagonist carteolol. A multicenter study].
    Rosprich G, Sölter H.
    Arzneimittelforschung; 1983 Aug; 33(2a):334-9. PubMed ID: 6682326
    [No Abstract] [Full Text] [Related]

  • 6. Antihypertensive effect of carteolol in thiazide-treated hypertensive subjects.
    Velasquez MT, Byrne D, Hoffmann RG.
    J Clin Pharmacol; 1985 Aug; 25(8):601-6. PubMed ID: 3908501
    [Abstract] [Full Text] [Related]

  • 7. [Hypotensive effect of carteolol in patients with essential hypertension].
    Beythien RD.
    Arzneimittelforschung; 1983 Aug; 33(2a):330-3. PubMed ID: 6682325
    [Abstract] [Full Text] [Related]

  • 8. Carteolol and penbutolol for hypertension.
    Med Lett Drugs Ther; 1989 Jul 28; 31(797):70-1. PubMed ID: 2568577
    [No Abstract] [Full Text] [Related]

  • 9. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C, Romanet JP, Nordmann JP, Allaire C, Groupe d'étude.
    J Fr Ophtalmol; 2003 Feb 28; 26(2):131-6. PubMed ID: 12660585
    [Abstract] [Full Text] [Related]

  • 10. [Antihypertensive treatment with captopril or carteolol in elderly patients].
    Murai A, Miyata S, Miyahara T, Sako Y.
    Nihon Ronen Igakkai Zasshi; 1987 Jan 28; 24(1):35-40. PubMed ID: 3298752
    [No Abstract] [Full Text] [Related]

  • 11. Effects of long-term treatment with low doses of carteolol on cardiovascular regulatory functions in elderly patients with mild hypertension.
    Shimada K, Kawamoto A, Matsubayashi K, Chikamori T, Kuzume O, Ozawa T.
    Clin Ther; 1990 Jan 28; 12(2):118-24. PubMed ID: 1972351
    [Abstract] [Full Text] [Related]

  • 12. [Clinical experiences with carteolol in patients with essential hypertension].
    Viehmann P.
    Arzneimittelforschung; 1983 Jan 28; 33(2a):322-5. PubMed ID: 6340701
    [Abstract] [Full Text] [Related]

  • 13. Circadian blood pressure change after carteolol chloride in younger and older hypertensive patients.
    Kuwajima I, Suzuki Y, Kuramoto K, Kawamura H, Otsuka K.
    Clin Ther; 1993 Jan 28; 15(2):338-46. PubMed ID: 8519042
    [Abstract] [Full Text] [Related]

  • 14. Time-dependent antihypertensive effect of carteolol--a beta-adrenoceptor antagonist with partial agonist activity.
    Giles TD, Sander GE, Kaneish A, Quiroz AC.
    Clin Pharmacol Ther; 1984 Mar 28; 35(3):301-6. PubMed ID: 6697637
    [Abstract] [Full Text] [Related]

  • 15. Carteolol, an antihypertensive beta-blocker with intrinsic sympathomimetic activity, reduces ECG evidence of left ventricular hypertrophy.
    Rosales OR, Sander GE, Roffidal L, Given MB, Giles TD.
    Chest; 1989 Jan 28; 95(1):43-7. PubMed ID: 2521204
    [Abstract] [Full Text] [Related]

  • 16. The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol.
    Simon H, Schuppan U.
    Arzneimittelforschung; 1983 Jan 28; 33(2a):318-21. PubMed ID: 6340700
    [Abstract] [Full Text] [Related]

  • 17. [Carteolol: general practice-oriented assessment of the effectiveness and tolerance of a new beta-blocker in the treatment of glaucoma].
    Schnaudigel OE, Becker H, Fuchs HB.
    Klin Monbl Augenheilkd; 1988 Mar 28; 192(3):248-51. PubMed ID: 3374015
    [Abstract] [Full Text] [Related]

  • 18. A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride.
    Tarkiainen A, Saraste K, Seppälä T, Gordin A, Auvinen J.
    Eur J Clin Pharmacol; 1981 Mar 28; 19(4):239-44. PubMed ID: 6116605
    [No Abstract] [Full Text] [Related]

  • 19. A double-crossover trial comparing the effects of topical carteolol and placebo on intraocular pressure.
    Duff GR, Graham PA.
    Br J Ophthalmol; 1988 Jan 28; 72(1):27-8. PubMed ID: 3277664
    [Abstract] [Full Text] [Related]

  • 20. [Carteolol in the treatment of open-angle glaucoma].
    Gorgone G, Randazzo S, Spina F.
    Ophtalmologie; 1988 Jan 28; 2(5):431-3. PubMed ID: 3244464
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.